These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 15568319

  • 1. [Use of dissolved ozone in the treatment of experimental tuberculosis in mice].
    Belianin II, Shmelev EI, Martynova LP, Nikonenko BV.
    Probl Tuberk Bolezn Legk; 2004; (10):36-9. PubMed ID: 15568319
    [Abstract] [Full Text] [Related]

  • 2. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
    Belianin II, Shmelev EI.
    Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
    [Abstract] [Full Text] [Related]

  • 3. [Dissolved ozone treatment-induced change in the resistance of multi-resistant mycobacterial strain to isoniazid and rifampicin].
    Belianin II, Martynova LP, Shmelev EI.
    Probl Tuberk; 2002; (1):46-9. PubMed ID: 11859807
    [Abstract] [Full Text] [Related]

  • 4. [Changes in drug resistance of Mycobacteria in the simultaneous use of chemotherapy and intravenous infusions of dissolved ozone].
    Belianin II, Shmelev EI.
    Probl Tuberk Bolezn Legk; 2004; (7):32-5. PubMed ID: 15379039
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Blood ozonation in the treatment of patients with progressive pulmonary tuberculosis concurrent with diabetes mellitus].
    Belianin II, Shmelev EI.
    Probl Tuberk; 1998; (1):30-3. PubMed ID: 9553431
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Influence of intravenous ozone treatment on the level of different specificity antibodies].
    Mandzhgaladze NR, Kharebava ER, Didia TsG, Ardzhevanishvili MD, Gudzhabidze MV, Chigiashvili TsN.
    Georgian Med News; 2006 Sep; (138):93-5. PubMed ID: 17057311
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.